NO20042244L - Fenylsubstituerte triazoler og deres anvendelse som selektive inhibitorer av AKL5-kinease - Google Patents
Fenylsubstituerte triazoler og deres anvendelse som selektive inhibitorer av AKL5-kineaseInfo
- Publication number
- NO20042244L NO20042244L NO20042244A NO20042244A NO20042244L NO 20042244 L NO20042244 L NO 20042244L NO 20042244 A NO20042244 A NO 20042244A NO 20042244 A NO20042244 A NO 20042244A NO 20042244 L NO20042244 L NO 20042244L
- Authority
- NO
- Norway
- Prior art keywords
- akl5
- kinase
- phenyl
- selective inhibitors
- substituted triazoles
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D285/00—Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups C07D275/00 - C07D283/00
- C07D285/01—Five-membered rings
- C07D285/02—Thiadiazoles; Hydrogenated thiadiazoles
- C07D285/14—Thiadiazoles; Hydrogenated thiadiazoles condensed with carbocyclic rings or ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/04—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles
- C07D249/06—1,2,3-Triazoles; Hydrogenated 1,2,3-triazoles with aryl radicals directly attached to ring atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D265/00—Heterocyclic compounds containing six-membered rings having one nitrogen atom and one oxygen atom as the only ring hetero atoms
- C07D265/28—1,4-Oxazines; Hydrogenated 1,4-oxazines
- C07D265/34—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings
- C07D265/36—1,4-Oxazines; Hydrogenated 1,4-oxazines condensed with carbocyclic rings condensed with one six-membered ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Physical Education & Sports Medicine (AREA)
- Biomedical Technology (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Urology & Nephrology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hospice & Palliative Care (AREA)
- Hematology (AREA)
- Heart & Thoracic Surgery (AREA)
- Psychiatry (AREA)
- Ophthalmology & Optometry (AREA)
- Vascular Medicine (AREA)
- Cardiology (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GBGB0127430.7A GB0127430D0 (en) | 2001-11-15 | 2001-11-15 | Compounds |
PCT/EP2002/013482 WO2003042211A1 (en) | 2001-11-15 | 2002-11-14 | Phenyl substituted triazoles and their use as selective inhibors of akl5 kinase |
Publications (1)
Publication Number | Publication Date |
---|---|
NO20042244L true NO20042244L (no) | 2004-07-13 |
Family
ID=9925832
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20042244A NO20042244L (no) | 2001-11-15 | 2004-05-28 | Fenylsubstituerte triazoler og deres anvendelse som selektive inhibitorer av AKL5-kinease |
Country Status (17)
Country | Link |
---|---|
US (1) | US20050014938A1 (no) |
EP (1) | EP1444232A1 (no) |
JP (1) | JP2005518352A (no) |
KR (1) | KR20050044476A (no) |
CN (1) | CN1608065A (no) |
BR (1) | BR0214160A (no) |
CA (1) | CA2467267A1 (no) |
GB (1) | GB0127430D0 (no) |
HU (1) | HUP0402227A2 (no) |
IL (1) | IL161852A0 (no) |
IS (1) | IS7252A (no) |
MX (1) | MXPA04004593A (no) |
NO (1) | NO20042244L (no) |
PL (1) | PL369605A1 (no) |
RU (1) | RU2004117862A (no) |
WO (1) | WO2003042211A1 (no) |
ZA (1) | ZA200403487B (no) |
Families Citing this family (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050165011A1 (en) * | 2002-05-15 | 2005-07-28 | Gellibert Francoise J. | Benzoxazine and benzoxazinone substituted triazoles |
GB0217787D0 (en) * | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | C ompounds |
GB0217780D0 (en) * | 2002-07-31 | 2002-09-11 | Glaxo Group Ltd | Compounds |
WO2004014900A1 (en) * | 2002-08-09 | 2004-02-19 | Eli Lilly And Company | Benzimidazoles and benzothiazoles as inhibitors of map kinase |
EP2261331A1 (en) | 2003-09-11 | 2010-12-15 | Hubit Genomix, Inc. | Method and kit for detecting proliferative diseases causing sclerosis, preventive and/or remedy for proliferative diseases causing sclerosis and method and kit for identifying substance efficacious in preventing and/or treating proliferative diseases causing sclerosis |
EP1720862A1 (en) * | 2004-02-03 | 2006-11-15 | Eli Lilly And Company | Kinase inhibitors |
JP2008508314A (ja) * | 2004-07-28 | 2008-03-21 | アイアールエム・リミテッド・ライアビリティ・カンパニー | ステロイドホルモン核内受容体のモジュレーターとしての化合物および組成物 |
ATE517897T1 (de) * | 2005-03-25 | 2011-08-15 | Tibotec Pharm Ltd | Heterobicyclische inhibitoren von hvc |
AR056347A1 (es) | 2005-05-12 | 2007-10-03 | Tibotec Pharm Ltd | Uso de compuestos de pteridina para fabricar medicamentos y composiciones farmaceuticas |
DE102005061840A1 (de) * | 2005-12-23 | 2007-06-28 | Merck Patent Gmbh | Triazolderivate |
BRPI0713951B8 (pt) | 2006-06-30 | 2021-05-25 | Novartis Ag | derivados de quinazolina, e composição farmacêutica |
JP5616063B2 (ja) * | 2006-10-04 | 2014-10-29 | ヤンセン・アールアンドデイ・アイルランド | Hcv阻害剤として有用なカルボキシアミド4−[(4−ピリジル)アミノ]ピリミジン |
EP1921072A1 (en) * | 2006-11-10 | 2008-05-14 | Laboratorios del Dr. Esteve S.A. | 1,2,3-Triazole derivatives as cannabinoid-receptor modulators |
US7678819B2 (en) * | 2006-12-07 | 2010-03-16 | The Trustees Of The University Of Pennsylvania | Acetylene derivatives and their use for binding and imaging amyloid plaques |
KR101076628B1 (ko) | 2008-07-09 | 2011-10-27 | 포항공과대학교 산학협력단 | 불균일 구리 나노 촉매 및 그 제조방법 |
WO2010005127A2 (en) | 2008-07-09 | 2010-01-14 | Postech Academy-Industry Foundation | Heterogeneous copper nanocatalyst and manufacturing methods thereof |
US8586581B2 (en) * | 2009-12-17 | 2013-11-19 | Hoffmann-La Roche Inc | Ethynyl compounds useful for treatment of CNS disorders |
CN102443009B (zh) * | 2010-09-30 | 2014-04-16 | 山东轩竹医药科技有限公司 | 并环激酶抑制剂 |
CN104520422B (zh) | 2012-05-30 | 2019-08-23 | 康奈尔大学 | 由人羊水来源的细胞生成功能性的和持久的内皮细胞 |
CN105473134B (zh) | 2013-06-05 | 2021-04-27 | 再生疗法有限公司 | 用于哺乳动物物种中诱导性组织再生的组合物和方法 |
US11078462B2 (en) | 2014-02-18 | 2021-08-03 | ReCyte Therapeutics, Inc. | Perivascular stromal cells from primate pluripotent stem cells |
US10240127B2 (en) | 2014-07-03 | 2019-03-26 | ReCyte Therapeutics, Inc. | Exosomes from clonal progenitor cells |
WO2022251359A1 (en) * | 2021-05-26 | 2022-12-01 | Theravance Biopharma R&D Ip, Llc | Bicyclic inhibitors of alk5 and methods of use |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2000010563A1 (en) * | 1998-08-20 | 2000-03-02 | Smithkline Beecham Corporation | Novel substituted triazole compounds |
DE60001229T2 (de) * | 1999-04-09 | 2003-10-30 | Smithkline Beecham Corp., Philadelphia | Triarylimidazole |
AR029803A1 (es) * | 2000-02-21 | 2003-07-16 | Smithkline Beecham Plc | Imidazoles sustituidos con piridilo y composiciones farmaceuticas que las comprenden |
GB0007405D0 (en) * | 2000-03-27 | 2000-05-17 | Smithkline Beecham Corp | Compounds |
JP2003530438A (ja) * | 2000-04-12 | 2003-10-14 | スミスクライン・ビーチャム・コーポレイション | 化合物および方法 |
GB0027987D0 (en) * | 2000-11-16 | 2001-01-03 | Smithkline Beecham Plc | Compounds |
-
2001
- 2001-11-15 GB GBGB0127430.7A patent/GB0127430D0/en not_active Ceased
-
2002
- 2002-11-14 CA CA002467267A patent/CA2467267A1/en not_active Abandoned
- 2002-11-14 MX MXPA04004593A patent/MXPA04004593A/es unknown
- 2002-11-14 IL IL16185202A patent/IL161852A0/xx unknown
- 2002-11-14 CN CNA028259149A patent/CN1608065A/zh active Pending
- 2002-11-14 BR BR0214160-4A patent/BR0214160A/pt not_active Application Discontinuation
- 2002-11-14 US US10/495,414 patent/US20050014938A1/en not_active Abandoned
- 2002-11-14 HU HU0402227A patent/HUP0402227A2/hu unknown
- 2002-11-14 RU RU2004117862/04A patent/RU2004117862A/ru not_active Application Discontinuation
- 2002-11-14 WO PCT/EP2002/013482 patent/WO2003042211A1/en not_active Application Discontinuation
- 2002-11-14 JP JP2003544047A patent/JP2005518352A/ja not_active Withdrawn
- 2002-11-14 PL PL02369605A patent/PL369605A1/xx not_active Application Discontinuation
- 2002-11-14 EP EP02803039A patent/EP1444232A1/en not_active Withdrawn
- 2002-11-14 KR KR1020047007378A patent/KR20050044476A/ko not_active Application Discontinuation
-
2004
- 2004-05-06 IS IS7252A patent/IS7252A/is unknown
- 2004-05-07 ZA ZA200403487A patent/ZA200403487B/en unknown
- 2004-05-28 NO NO20042244A patent/NO20042244L/no not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO2003042211A1 (en) | 2003-05-22 |
CN1608065A (zh) | 2005-04-20 |
US20050014938A1 (en) | 2005-01-20 |
JP2005518352A (ja) | 2005-06-23 |
RU2004117862A (ru) | 2006-01-10 |
EP1444232A1 (en) | 2004-08-11 |
PL369605A1 (en) | 2005-05-02 |
KR20050044476A (ko) | 2005-05-12 |
GB0127430D0 (en) | 2002-01-09 |
BR0214160A (pt) | 2004-09-28 |
CA2467267A1 (en) | 2003-05-22 |
HUP0402227A2 (hu) | 2005-02-28 |
IL161852A0 (en) | 2005-11-20 |
MXPA04004593A (es) | 2004-08-13 |
IS7252A (is) | 2004-05-06 |
ZA200403487B (en) | 2006-05-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20042244L (no) | Fenylsubstituerte triazoler og deres anvendelse som selektive inhibitorer av AKL5-kinease | |
NO20026010D0 (no) | Substituerte quinazolinderivater og deres anvendelse som inhibitorer | |
DK1480962T3 (da) | 5-Phenylthiazol-derivater og deres anvendelse som P1-3-kinaseinhibitorer | |
IS2529B (is) | Nýjar spírótrísýklískar afleiður og notkun þeirra sem fosfódíesterasa-7-hindrar | |
NO20050636L (no) | Inhibitorer av tyrosinkinaser | |
NO20030958D0 (no) | Pyrazolderivater og deres anvendelse som proteinkinase inhibitorer | |
DK1133477T3 (da) | Substituerede benzimidazoler og deres anvendelse som parpinhibitorer | |
NO20053242D0 (no) | 4-substituerte benzimidazoler og deres anvendelse som inhibitorer av gastrisk sekresjon. | |
MXPA03006420A (es) | Diaminotiazoles. | |
NO20042634L (no) | 3-Cyanokinoliner som inhibitorer for EGF-R og HER2-kinaser | |
NO20041582L (no) | Antistoffinhibitorer av GDF-8 og anvendelse derav | |
DK1499311T3 (da) | Substituerede benzaboler og anvendelse deraf som RAF-kinaseinhibitorer | |
IS7792A (is) | Hýdantóínafleiður og notkun þeirra sem TACE hemla | |
NO20023319D0 (no) | Substituerte glutarimider og deres anvendelse som inhibitorer av IL-12-produksjonen | |
NO20052888D0 (no) | Diamintriazoler anvendelige som inhibitorer av proteinkinaser | |
NO20034324D0 (no) | Bipiperidinylderivater og deres anvendelse som kjemokin reseptorinhibitor | |
NO20042719L (no) | Substituerte 2-amino-cykloalkankarboksamider og deres anvendelse som protease-inhibitorer | |
DK1387838T3 (da) | Cyanoanthranylamid-derivater og deres anvendelse som lægemidler | |
NO20034434L (no) | Indolinoner substituert i 6-stilling og deres anvendelse som kinase-inhibitorer | |
PL369742A1 (en) | Inhibitors of cyclin-dependent kinases, compositions and uses related thereto | |
AU2003210983A8 (en) | Kinase inhibitors and methods of use thereof | |
NO20041938L (no) | Anvendelse av fosfodiesterase IV-inhibitorer | |
NO20025884D0 (no) | 2-aminotiazolinderivater og deres anvendelse som NO- syntaseinhibitorer | |
MXPA03006423A (es) | Naftostirilos. | |
NO20025885L (no) | Derivater av 4,5-dihydro-tiazo-2-ylamin og deres anvendelse som NO-syntaseinhibitorer |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |